S&D Shares Plunge Over 17% as Samyang Foods Moves to Acquire Sauce Supplier G&F

Reporter Kim Jisun / approved : 2025-07-15 03:16:04
  • -
  • +
  • 인쇄

 

 

[Alpha Biz= Kim Jisun] SEOUL, July 14 – Shares of S&D Co., a key ingredient supplier for Samyang Foods, tumbled more than 17% on concerns over the potential erosion of its exclusive supply position.



S&D closed at 1,084,000 KRW on the KOSDAQ on Monday, down 17.69% from the previous session. During intraday trading, shares fell as much as 25.89% to 976,000 KRW. The sell-off was driven by news that Samyang Foods has signed a stock purchase agreement (SPA) to acquire 100% of local sauce producer G&F for an estimated 60 billion KRW.



The move marks Samyang's first major M&A deal in nearly a decade, following its acquisition of frozen food company Saeachim (now Samyang Square Meal) in 2015.



S&D currently supplies key sauce ingredients for Samyang’s flagship Buldak-bokkeum-myeon spicy noodle line. Market participants fear that Samyang’s acquisition of G&F could lead to internalization of sauce production, threatening S&D’s sales and profit margins.



Foreign and retail investors offloaded S&D shares worth approximately 5.15 billion KRW and 660 million KRW, respectively.



G&F, the acquisition target, is known for supplying soup bases to other major Korean food companies, including Nongshim and Ottogi. In 2023, G&F posted revenue of 41.7 billion KRW and an operating profit of 3.2 billion KRW.



Samyang Foods shares also dipped slightly, closing at 1,462,000 KRW, down 0.54% on the day.

 

 

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

NAVER Secures 60,000 NVIDIA Blackwell GPUs to Lead Industrial AI Innovation2025.11.01
Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사